This qualitative sub-study of the discontinuation phase of the CTN-0100 research study will examine the experiences of people who have attempted to stop buprenorphine for treatment of opioid use disorder to determine why some people are able to stop buprenorphine for treatment of opioid use disorder while others are not and identify risk factors for return to non-prescribed opioid use when someone is tapering off buprenorphine.
Principal Investigator(s)
Mat Kladney, M.D.
462 First Avenue
New York, NY 10016
United States